Euan Macpherson

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

Jonathan A. Ledermann, Philipp Harter, Charlie Gourley et al. · New England Journal of Medicine · 2012 · 1.9K citations

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Karen A. Gelmon, Marc Tischkowitz, Helen Mackay et al. · The Lancet Oncology · 2011 · 1.1K citations

Breast Oncology, Medicine, Gynecology +9

Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study

J.F.R. Robertson, Antonio Llombart‐Cussac, Janusz Rolski et al. · Journal of Clinical Oncology · 2009 · 311 citations

Evaluation of the repeatability of ultra-performance liquid chromatography–TOF-MS for global metabolic profiling of human urine samples

Helen Gika, Euan Macpherson, Georgios Theodoridis et al. · Journal of Chromatography B · 2008 · 227 citations

Metabolomic Profiling, Global Metabolic Profiling, Bioanalysis +17

Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study

Jens Samol, Malcolm Ranson, Edwina N. Scott et al. · Investigational New Drugs · 2011 · 154 citations

Medicine, Cancer Management, Pharmacology +8